Linked Data API

Show Search Form

Search Results

1399150
human indexable true more like this
published true more like this
registered interest false more like this
answer date remove filter
date less than 2022-01-04more like thismore than 2022-01-04
date tabled less than 2022-01-04more like thismore than 2022-01-04
ddp created less than 2022-01-04T14:56:04.137Zmore like thismore than 2022-01-04T14:56:04.137Z
answering body
Department of Health and Social Care remove filter
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2022-01-04T15:05:36.095Zmore like thismore than 2022-01-04T15:05:36.095Z
less than 2022-01-11T10:00:23.724Zmore like thismore than 2022-01-11T10:00:23.724Z
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
identifier 96908 more like this
legislature
25259
parliament number 58 more like this
question first answered
less than 2022-01-11T09:29:32.533Zmore like thismore than 2022-01-11T09:29:32.533Z
question text To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on their (a) current and (b) future capacity to deliver final draft guidance on medicines within three months of regulatory approval by the MHRA. more like this
session
2021/22 more like this
session number 2 more like this
tabling member constituency Bolton West more like this
tabling member printed
Chris Green more like this
title House of Commons Tabled Parliamentary Question 2021/22 96908 more like this
type
WrittenParliamentaryQuestion
uin 96908 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4398
label Biography information for Chris Green more like this
publisher 25259
tabling member
4398
label Biography information for Chris Green more like this
1399156
human indexable true more like this
published true more like this
registered interest false more like this
answer date remove filter
date less than 2022-01-04more like thismore than 2022-01-04
date tabled less than 2022-01-04more like thismore than 2022-01-04
ddp created less than 2022-01-04T14:56:17.973Zmore like thismore than 2022-01-04T14:56:17.973Z
answering body
Department of Health and Social Care remove filter
question status Tabled more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
ddp modified
less than 2022-01-04T15:15:25.951Zmore like thismore than 2022-01-04T15:15:25.951Z
less than 2022-01-11T10:00:20.425Zmore like thismore than 2022-01-11T10:00:20.425Z
hansard heading National Institute for Health and Care Excellence remove filter
house id 1 more like this
identifier 96910 more like this
legislature
25259
parliament number 58 more like this
question first answered
less than 2022-01-11T09:29:32.66Zmore like thismore than 2022-01-11T09:29:32.66Z
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of operational challenges faced by NICE on its ability to deliver timely patient access to new medicines. more like this
session
2021/22 more like this
session number 2 more like this
tabling member constituency Bolton West more like this
tabling member printed
Chris Green more like this
title House of Commons Tabled Parliamentary Question 2021/22 96910 more like this
type
WrittenParliamentaryQuestion
uin 96910 more like this
version 1 more like this
written parliamentary question type Ordinary more like this
answer answer
creator
4398
label Biography information for Chris Green more like this
publisher 25259
tabling member
4398
label Biography information for Chris Green more like this